SciSparc Ltd. (SPRC)
5.10
-0.19
(-3.59%)
USD |
NASDAQ |
Sep 08, 16:00
5.07
-0.03
(-0.59%)
Pre-Market: 08:26
SciSparc Enterprise Value : -0.2489M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -0.2489M |
| September 04, 2026 | -0.2412M |
| September 03, 2026 | -0.2477M |
| September 02, 2026 | -0.2185M |
| September 01, 2026 | -0.2258M |
| August 31, 2026 | -0.1868M |
| August 28, 2026 | -0.1889M |
| August 27, 2026 | -0.1872M |
| August 26, 2026 | -0.1824M |
| August 25, 2026 | -0.1844M |
| August 24, 2026 | -0.1856M |
| August 21, 2026 | -0.1842M |
| August 20, 2026 | -0.187M |
| August 19, 2026 | -0.1775M |
| August 18, 2026 | -0.1917M |
| August 17, 2026 | -0.1864M |
| August 14, 2026 | -0.1884M |
| August 13, 2026 | -0.1844M |
| August 12, 2026 | -0.188M |
| August 11, 2026 | -0.1791M |
| August 10, 2026 | -0.1876M |
| August 07, 2026 | -0.1746M |
| August 06, 2026 | -0.1832M |
| August 05, 2026 | -0.1763M |
| August 04, 2026 | -0.1824M |
| Date | Value |
|---|---|
| August 03, 2026 | -0.1653M |
| July 31, 2026 | -0.1669M |
| July 30, 2026 | -0.1028M |
| July 29, 2026 | -0.0869M |
| July 28, 2026 | -0.2396M |
| July 27, 2026 | -0.2526M |
| July 24, 2026 | -0.2396M |
| July 23, 2026 | -0.2238M |
| July 22, 2026 | -0.2595M |
| July 21, 2026 | -0.2632M |
| July 20, 2026 | -0.2652M |
| July 17, 2026 | -0.253M |
| July 16, 2026 | -0.2384M |
| July 15, 2026 | -0.2571M |
| July 14, 2026 | -0.2826M |
| July 13, 2026 | -0.2705M |
| July 10, 2026 | -0.2652M |
| July 09, 2026 | -0.2347M |
| July 08, 2026 | -0.2331M |
| July 07, 2026 | -0.2538M |
| July 06, 2026 | -0.2648M |
| July 02, 2026 | -0.2619M |
| July 01, 2026 | -0.2469M |
| June 30, 2026 | -0.2319M |
| June 29, 2026 | -0.2282M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 56.05B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 147.71M |
| Purple Biotech Ltd. | -3.116M |
| Sol-Gel Technologies Ltd. | 179.96M |
Enterprise Value Related Metrics
| Earnings Yield | -4.54K% |
| Normalized Earnings Yield | -4500.21 |